MICRO21 WITH NDNA

Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control

TRIANGLE BIOMEDICAL SCIENCES, INC.

The following data is part of a premarket notification filed by Triangle Biomedical Sciences, Inc. with the FDA for Micro21 With Ndna.

Pre-market Notification Details

Device IDK964165
510k NumberK964165
Device Name:MICRO21 WITH NDNA
ClassificationAntinuclear Antibody, Indirect Immunofluorescent, Antigen, Control
Applicant TRIANGLE BIOMEDICAL SCIENCES, INC. 4360 NORTHLAKE BLVD. SUITE 214 Palm Beach Gardens,  FL  33410
ContactR. Otto Stellner
CorrespondentR. Otto Stellner
TRIANGLE BIOMEDICAL SCIENCES, INC. 4360 NORTHLAKE BLVD. SUITE 214 Palm Beach Gardens,  FL  33410
Product CodeDHN  
CFR Regulation Number866.5100 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1996-10-17
Decision Date1997-01-03
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.